메뉴 건너뛰기




Volumn 30, Issue 5, 2009, Pages 531-538

Genetics of cystic fibrosis

Author keywords

Congenital bilateral absence of the vas deferens (CBAVD); Cystic fibrosis transmembrane regulator (CFTR); F508; Idiopathic chronic pancreatitis (ICP); Mutations; Newborn screening (NBS)

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

EID: 70350452926     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0029-1238911     Document Type: Review
Times cited : (32)

References (46)
  • 1
    • 0003766974 scopus 로고    scopus 로고
    • History of cystic fibrosis In: Hodson M, Geddes D, Bush A London Hodder Arnold
    • Littlewood J M. History of cystic fibrosis In: Hodson M, Geddes D, Bush A Cystic Fibrosis. London Hodder Arnold 2007 3-19
    • (2007) Cystic Fibrosis , pp. 3-19
    • Littlewood, J.M.1
  • 2
    • 0031900652 scopus 로고    scopus 로고
    • The diagnosis of cystic fibrosis: A consensus statement
    • Cystic Fibrosis Foundation Consensus Panel
    • Rosenstein B J., Cutting G R., Cystic Fibrosis Foundation Consensus Panel. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998 132 589-595
    • (1998) J Pediatr , vol.132 , pp. 589-595
    • Rosenstein, B.J.1    Cutting, G.R.2
  • 3
    • 0037043650 scopus 로고    scopus 로고
    • What is cystic fibrosis?
    • Knowles M R., Durie P R. What is cystic fibrosis? N Engl J Med 2002 347 439-442
    • (2002) N Engl J Med , vol.347 , pp. 439-442
    • Knowles, M.R.1    Durie, P.R.2
  • 4
    • 84920211040 scopus 로고
    • Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; Clinical significance and relationship to the disease
    • Di SantAgnese P A., Darling R C., Perera G A., Shea E. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease. Pediatrics 1953 12 549-563
    • (1953) Pediatrics , vol.12 , pp. 549-563
    • Di Santagnese, P.A.1    Darling, R.C.2    Perera, G.A.3    Shea, E.4
  • 5
    • 70350507609 scopus 로고    scopus 로고
    • Cystic Fibrosis Transmembrane Conductance Regulator 1998 http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602421
    • Cystic Fibrosis Transmembrane Conductance Regulator. CFTR. 1998 http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602421 Accessed April 2009
    • (2009) CFTR
  • 6
    • 0034109607 scopus 로고    scopus 로고
    • Genotype and phenotype in cystic fibrosis
    • Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 2000 67 117-133
    • (2000) Respiration , vol.67 , pp. 117-133
    • Zielenski, J.1
  • 8
    • 49449102389 scopus 로고    scopus 로고
    • Molecular biology of cystic fibrosis: CFTR processing and functions, and classes of mutations In: Hodson M, Geddes D, Bush A London Hodder Arnold
    • Nissim-Rafinia M, Kerem B, Kerem E. Molecular biology of cystic fibrosis: CFTR processing and functions, and classes of mutations In: Hodson M, Geddes D, Bush A Cystic Fibrosis. 3rd ed. London Hodder Arnold 2007 49-58
    • (2007) Cystic Fibrosis. 3rd Ed , pp. 49-58
    • Nissim-Rafinia, M.1    Kerem, B.2    Kerem, E.3
  • 9
    • 0027162649 scopus 로고
    • Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
    • Welsh M J., Smith A E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993 73 1251-1254
    • (1993) Cell , vol.73 , pp. 1251-1254
    • Welsh, M.J.1    Smith, A.E.2
  • 10
    • 0035722764 scopus 로고    scopus 로고
    • CFTR-opathies: Disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
    • Noone P G., Knowles M R. CFTR-opathies: disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2001 2 328-332
    • (2001) Respir Res , vol.2 , pp. 328-332
    • Noone, P.G.1    Knowles, M.R.2
  • 11
    • 0028062781 scopus 로고
    • Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model
    • Gabriel S E., Brigman K N., Koller B H., Boucher R C., Stutts M J. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 1994 266 107-109
    • (1994) Science , vol.266 , pp. 107-109
    • Gabriel, S.E.1    Brigman, K.N.2    Koller, B.H.3    Boucher, R.C.4    Stutts, M.J.5
  • 12
    • 0036181136 scopus 로고    scopus 로고
    • Genetic screening for maternal uniparental disomy of chromosome 7 in prenatal and postnatal growth retardation of unknown cause
    • Hannula K, Lipsanen-Nyman M, Kristo P et al. Genetic screening for maternal uniparental disomy of chromosome 7 in prenatal and postnatal growth retardation of unknown cause. Pediatrics 2002 109 441-448
    • (2002) Pediatrics , vol.109 , pp. 441-448
    • Hannula, K.1    Lipsanen-Nyman, M.2    Kristo, P.3
  • 13
    • 0004273715 scopus 로고    scopus 로고
    • Diagnosis and clinical phenotype In: Yankaskas JR, Knowles MR Philadelphia Lippincott-Raven
    • Knowles M RF, Silverman K J., Genetics L M. Diagnosis and clinical phenotype In: Yankaskas JR, Knowles MR Cystic Fibrosis in Adults. Philadelphia Lippincott-Raven 1999 27-42
    • (1999) Cystic Fibrosis in Adults , pp. 27-42
    • Knowles, M.R.1    Silverman, K.J.2    Genetics, L.M.3
  • 14
    • 0028175683 scopus 로고
    • Genetic analysis of Hispanic individuals with cystic fibrosis
    • Grebe T A., Seltzer W K., DeMarchi J et al. Genetic analysis of Hispanic individuals with cystic fibrosis. Am J Hum Genet 1994 54 443-446
    • (1994) Am J Hum Genet , vol.54 , pp. 443-446
    • Grebe, T.A.1    Seltzer, W.K.2    Demarchi, J.3
  • 15
    • 25844516389 scopus 로고    scopus 로고
    • Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe
    • Dankert-Roelse J E., Mrelle M E. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr 2005 147 (3, Suppl) S15-S20
    • (2005) J Pediatr , vol.147 , Issue.SUPPL
    • Dankert-Roelse, J.E.1    Mrelle, M.E.2
  • 16
    • 70350508676 scopus 로고    scopus 로고
    • Cystic Fibrosis Foundation Available at http://www.cff.org/AboutCF/ Testing/NewbornScreening/
    • Cystic Fibrosis Foundation. Newborn Screening. 2008. Available at http://www.cff.org/AboutCF/Testing/NewbornScreening/
    • Newborn Screening. 2008
  • 17
    • 47049115524 scopus 로고    scopus 로고
    • Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report
    • Cystic Fibrosis Foundation
    • Farrell P M., Rosenstein B J., White T B. et al, Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008 153 S4-S14
    • (2008) J Pediatr , vol.153
    • Farrell, P.M.1    Rosenstein, B.J.2    White, T.B.3
  • 18
    • 33947141892 scopus 로고    scopus 로고
    • Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report
    • Cystic Fibrosis Foundation
    • Comeau A M., Accurso F J., White T B. et al, Cystic Fibrosis Foundation. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics 2007 119 e495-e518
    • (2007) Pediatrics , vol.119
    • Comeau, A.M.1    Accurso, F.J.2    White, T.B.3
  • 19
    • 0027302429 scopus 로고
    • Immunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileus
    • Rusakow L SAS, Sokol R J., Seltzer W, Hammond K, Accurso R J. Immunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileus. Screening 1993 2 13-17
    • (1993) Screening , vol.2 , pp. 13-17
    • Rusakow, L.S.1    Sokol, R.J.2    Seltzer, W.3    Hammond, K.4    Accurso, R.J.5
  • 20
    • 0029558007 scopus 로고
    • Neonatal screening for cystic fibrosis: A comparison of two strategies for case detection in 1.2 million babies
    • Wilcken B, Wiley V, Sherry G, Bayliss U. Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies. J Pediatr 1995 127 965-970
    • (1995) J Pediatr , vol.127 , pp. 965-970
    • Wilcken, B.1    Wiley, V.2    Sherry, G.3    Bayliss, U.4
  • 21
    • 0036766526 scopus 로고    scopus 로고
    • Comparison of two different protocols of neonatal screening for cystic fibrosis
    • Narzi L, Lucarelli M, Lelli A et al. Comparison of two different protocols of neonatal screening for cystic fibrosis. Clin Genet 2002 62 245-249
    • (2002) Clin Genet , vol.62 , pp. 245-249
    • Narzi, L.1    Lucarelli, M.2    Lelli, A.3
  • 22
    • 70350493289 scopus 로고    scopus 로고
    • Cystic Fibrosis Mutation Database Available at: http://www.genet. sickkids.on.ca/cftr/app
    • Cystic Fibrosis Mutation Database. Available at: http://www.genet. sickkids.on.ca/cftr/app
  • 23
    • 4644361735 scopus 로고    scopus 로고
    • Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel
    • Watson M S., Cutting G R., Desnick R J. et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 2004 6 387-391
    • (2004) Genet Med , vol.6 , pp. 387-391
    • Watson, M.S.1    Cutting, G.R.2    Desnick, R.J.3
  • 24
    • 34250621406 scopus 로고    scopus 로고
    • Diagnostic sweat testing: The Cystic Fibrosis Foundation guidelines
    • Cystic Fibrosis Foundation
    • LeGrys V A., Yankaskas J R., Quittell L M., Marshall B C., Mogayzel P J. Jr, Cystic Fibrosis Foundation. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr 2007 151 85-89
    • (2007) J Pediatr , vol.151 , pp. 85-89
    • Legrys, V.A.1    Yankaskas, J.R.2    Quittell, L.M.3    Marshall, B.C.4    Mogayzel, Jr.P.J.5
  • 25
    • 42149120706 scopus 로고    scopus 로고
    • Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function
    • Serohijos A WRH, Hegedus T, Aleksandrov A A. et al. Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A 2008 105 3256-3261
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 3256-3261
    • Serohijos, A.W.1    Hegedus, T.2    Aleksandrov, A.A.3
  • 26
    • 0029118117 scopus 로고
    • Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents
    • Fulmer S B., Schwiebert E M., Morales M M., Guggino W B., Cutting G R. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. Proc Natl Acad Sci U S A 1995 92 6832-6836
    • (1995) Proc Natl Acad Sci U S A , vol.92 , pp. 6832-6836
    • Fulmer, S.B.1    Schwiebert, E.M.2    Morales, M.M.3    Guggino, W.B.4    Cutting, G.R.5
  • 27
    • 0029826866 scopus 로고    scopus 로고
    • Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator
    • McNicholas C M., Guggino W B., Schwiebert E M., Hebert S C., Giebisch G, Egan M E. Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator. Proc Natl Acad Sci U S A 1996 93 8083-8088
    • (1996) Proc Natl Acad Sci U S A , vol.93 , pp. 8083-8088
    • McNicholas, C.M.1    Guggino, W.B.2    Schwiebert, E.M.3    Hebert, S.C.4    Giebisch, G.5    Egan, M.E.6
  • 28
    • 0028264188 scopus 로고
    • Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator
    • Akabas M H., Kaufmann C, Cook T A., Archdeacon P. Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 1994 269 14865-14868
    • (1994) J Biol Chem , vol.269 , pp. 14865-14868
    • Akabas, M.H.1    Kaufmann, C.2    Cook, T.A.3    Archdeacon, P.4
  • 29
    • 0036498543 scopus 로고    scopus 로고
    • Splicing regulation as a potential genetic modifier
    • Nissim-Rafinia M KB, Kerem B. Splicing regulation as a potential genetic modifier. Trends Genet 2002 18 123-127
    • (2002) Trends Genet , vol.18 , pp. 123-127
    • Nissim-Rafinia, M.K.1    Kerem, B.2
  • 30
    • 10044270719 scopus 로고    scopus 로고
    • Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation
    • Nissim-Rafinia M, Aviram M, Randell S H. et al. Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. EMBO Rep 2004 5 1071-1077
    • (2004) EMBO Rep , vol.5 , pp. 1071-1077
    • Nissim-Rafinia, M.1    Aviram, M.2    Randell, S.H.3
  • 31
    • 0033618404 scopus 로고    scopus 로고
    • C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis: A novel class of mutation
    • Haardt M, Benharouga M, Lechardeur D, Kartner N, Lukacs G L. C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis: a novel class of mutation. J Biol Chem 1999 274 21873-21877
    • (1999) J Biol Chem , vol.274 , pp. 21873-21877
    • Haardt, M.1    Benharouga, M.2    Lechardeur, D.3    Kartner, N.4    Lukacs, G.L.5
  • 32
    • 0029025333 scopus 로고
    • Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
    • Chilln M, Casals T, Mercier B et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995 332 1475-1480
    • (1995) N Engl J Med , vol.332 , pp. 1475-1480
    • Chilln, M.1    Casals, T.2    Mercier, B.3
  • 33
    • 0032975778 scopus 로고    scopus 로고
    • Clinical and genetic risk factors for cystic fibrosisrelated liver disease
    • Wilschanski M, Rivlin J, Cohen S et al. Clinical and genetic risk factors for cystic fibrosisrelated liver disease. Pediatrics 1999 103 52-57
    • (1999) Pediatrics , vol.103 , pp. 52-57
    • Wilschanski, M.1    Rivlin, J.2    Cohen, S.3
  • 34
    • 0032480253 scopus 로고    scopus 로고
    • Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
    • Sharer N, Schwarz M, Malone G et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998 339 645-652
    • (1998) N Engl J Med , vol.339 , pp. 645-652
    • Sharer, N.1    Schwarz, M.2    Malone, G.3
  • 35
    • 34547164336 scopus 로고    scopus 로고
    • Patterns of GI disease in adulthood associated with mutations in the CFTR gene
    • Wilschanski M, Durie P R. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 2007 56 1153-1163
    • (2007) Gut , vol.56 , pp. 1153-1163
    • Wilschanski, M.1    Durie, P.R.2
  • 36
    • 0035213536 scopus 로고    scopus 로고
    • Cystic fibrosis gene mutations and pancreatitis risk: Relation to epithelial ion transport and trypsin inhibitor gene mutations
    • Noone P G., Zhou Z, Silverman L M., Jowell P S., Knowles M R., Cohn J A. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001 121 1310-1319
    • (2001) Gastroenterology , vol.121 , pp. 1310-1319
    • Noone, P.G.1    Zhou, Z.2    Silverman, L.M.3    Jowell, P.S.4    Knowles, M.R.5    Cohn, J.A.6
  • 37
    • 25444506869 scopus 로고    scopus 로고
    • Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers
    • Cohn J A., Neoptolemos J P., Feng J et al. Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers. Hum Mutat 2005 26 303-307
    • (2005) Hum Mutat , vol.26 , pp. 303-307
    • Cohn, J.A.1    Neoptolemos, J.P.2    Feng, J.3
  • 39
    • 15444366704 scopus 로고    scopus 로고
    • Reduced CFTR function and the pathobiology of idiopathic pancreatitis
    • Cohn J A. Reduced CFTR function and the pathobiology of idiopathic pancreatitis. J Clin Gastroenterol 2005 39 (4, Suppl 2) S70-S77
    • (2005) J Clin Gastroenterol , vol.39 , Issue.SUPPL 2
    • Cohn, J.A.1
  • 40
    • 34848857401 scopus 로고    scopus 로고
    • Genetic modifiers of severe liver disease in cystic fibrosis
    • abstract 170
    • Friedman K J., Ling S C., Lange E M. et al. Genetic modifiers of severe liver disease in cystic fibrosis. Pediatr Pulmonol 2005 40 (Suppl 28) 247 abstract 170
    • (2005) Pediatr Pulmonol , vol.40 , Issue.SUPPL 28 , pp. 247
    • Friedman, K.J.1    Ling, S.C.2    Lange, E.M.3
  • 41
    • 34249654482 scopus 로고    scopus 로고
    • Large genomic rearrangements in the CFTR gene contribute to CBAVD
    • Taulan M, Girardet A, Guittard C et al. Large genomic rearrangements in the CFTR gene contribute to CBAVD. BMC Med Genet 2007 8 22
    • (2007) BMC Med Genet , vol.8 , pp. 22
    • Taulan, M.1    Girardet, A.2    Guittard, C.3
  • 42
    • 34250180679 scopus 로고    scopus 로고
    • Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling
    • Ratbi I, Legendre M, Niel F et al. Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling. Hum Reprod 2007 22 1285-1291
    • (2007) Hum Reprod , vol.22 , pp. 1285-1291
    • Ratbi, I.1    Legendre, M.2    Niel, F.3
  • 43
    • 0027517995 scopus 로고
    • Correlation between genotype and phenotype in patients with cystic fibrosis
    • The Cystic Fibrosis Genotype-Phenotype Consortium
    • The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993 329 1308-1313
    • (1993) N Engl J Med , vol.329 , pp. 1308-1313
  • 44
    • 0013235689 scopus 로고    scopus 로고
    • Analysis of cystic fibrosis transmembrane conductance regulator gene mutations in patients with congenital absence of the uterus and vagina
    • Timmreck L S., Gray M R., Handelin B et al. Analysis of cystic fibrosis transmembrane conductance regulator gene mutations in patients with congenital absence of the uterus and vagina. Am J Med Genet A 2003 120A 72-76
    • (2003) Am J Med Genet A , vol.120 , pp. 72-76
    • Timmreck, L.S.1    Gray, M.R.2    Handelin, B.3
  • 45
    • 52949149656 scopus 로고    scopus 로고
    • Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus, and vagina as a cause of infertility
    • Radpour R, Gourabi H, Dizaj A V., Holzgreve W, Zhong X Y. Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus, and vagina as a cause of infertility. J Androl 2008 29 506-513
    • (2008) J Androl , vol.29 , pp. 506-513
    • Radpour, R.1    Gourabi, H.2    Dizaj, A.V.3    Holzgreve, W.4    Zhong, X.Y.5
  • 46
    • 13444305413 scopus 로고    scopus 로고
    • Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor
    • King S J., Topliss D J., Kotsimbos T et al. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor. Eur Respir J 2005 25 54-61
    • (2005) Eur Respir J , vol.25 , pp. 54-61
    • King, S.J.1    Topliss, D.J.2    Kotsimbos, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.